1
|
El Zoghbi M, Salameh P, Stücker I, Paris C, Pairon JC, Gislard A, Siemiatycki J, Bonneterre V, Clin B, Brochard P, Delva F, Lacourt A. Prevalence of occupational exposure to asbestos and crystalline silica according to phenotypes of lung cancer from the CaProMat study: A case-only study. Am J Ind Med 2018; 61:85-99. [PMID: 29086993 DOI: 10.1002/ajim.22765] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/07/2017] [Indexed: 12/28/2022]
Abstract
BACKGROUND The objective of the study was to compare the prevalence of occupational exposure to asbestos and crystalline silica according to histological types of lung cancer and age at diagnosis. METHODS CaProMat study is a pooled case-only study conducted between 1996 and 2011. The current study consisted of 6521 lung cancer cases. Occupational exposure to asbestos and crystalline silica was assessed by two Job-Exposure Matrices. A weighted prevalence of exposure was derived and compared according to histological types and age at diagnosis. RESULTS There was no difference of weighted prevalence of exposure to asbestos and crystalline silica according to histological types of lung cancer. There was a statistically significant difference of weighted prevalence of exposure to asbestos and crystalline silica according to age at diagnosis. CONCLUSIONS Due to the limited clinical importance of the difference, neither the histological type, nor the age at diagnosis can be used as an indicator for the occupational exposure to asbestos or crystalline silica.
Collapse
Affiliation(s)
- Mohamad El Zoghbi
- University of Bordeaux, ISPED, INSERM U1219-Bordeaux Population Heath Center INSERM U1219, EPICENE; Bordeaux France
- INSERM, ISPED, U1219-Bordeaux Population Heath Center U1219, EPICENE; Bordeaux France
| | - Pascale Salameh
- Lebanese University, Faculty of Medical Sciences; Beirut Lebanon
| | - Isabelle Stücker
- Université Paris Saclay, Univ. Paris-Sud, UVSQ, CESP, INSERM; Villejuif France
| | - Christophe Paris
- EA 7298 INGRES, Faculté de Médecine, Université de Lorraine; Vandœuvre-lès-Nancy France
- Center de consultations de pathologies professionnelles; CHU Nancy Vandœuvre-lès-Nancy France
| | - Jean C. Pairon
- INSERM, U955, Equipe 4; Créteil France
- Faculté de Médecine, Université Paris-Est Créteil; Créteil France
- Institut Santé Travail Paris-Est, Université Paris-Est Créteil; Créteil France
- Service de Pneumologie et Pathologie Professionnelle, DHU A-TVB, CHI Créteil; Créteil France
| | - Antoine Gislard
- Occupational Diseases Department, University Hospital; Rouen France
| | - Jack Siemiatycki
- University of Montreal Hospital Research Center (CRCHUM), 850 rue St-Denis, Montreal, Quebec, H2x 0A9; Canada
- Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal; Quebec Canada
- Guzzo-Cancer Research Society Chair in Environment and Cancer, School of Public Health, University of Montreal, Montreal; Quebec Canada
| | - Vincent Bonneterre
- Occupational Diseases Clinic, Grenoble-Alpes Teaching Hospital (CHU Grenoble-Alpes), Grenoble cedex 9; France
- Grenoble-Alpes University/CNRS/TIMC research laboratory UMR 5525 (EPSP Team), La Tronche cedex; France
| | - Bénédicte Clin
- Service de santé au travail et pathologie professionnelle, CHU Caen; Caen France
- INSERM, UMR 1086, Cancers et Populations; Caen France
- Faculté de Médecine, Université de Caen; Caen France
| | - Patrick Brochard
- University of Bordeaux, ISPED, INSERM U1219-Bordeaux Population Heath Center INSERM U1219, EPICENE; Bordeaux France
| | - Fleur Delva
- University of Bordeaux, ISPED, INSERM U1219-Bordeaux Population Heath Center INSERM U1219, EPICENE; Bordeaux France
- INSERM, ISPED, U1219-Bordeaux Population Heath Center U1219, EPICENE; Bordeaux France
| | - Aude Lacourt
- University of Bordeaux, ISPED, INSERM U1219-Bordeaux Population Heath Center INSERM U1219, EPICENE; Bordeaux France
- INSERM, ISPED, U1219-Bordeaux Population Heath Center U1219, EPICENE; Bordeaux France
| |
Collapse
|
2
|
Alif SM, Dharmage SC, Benke G, Dennekamp M, Burgess JA, Perret JL, Lodge CJ, Morrison S, Johns DP, Giles GG, Gurrin LC, Thomas PS, Hopper JL, Wood-Baker R, Thompson BR, Feather IH, Vermeulen R, Kromhout H, Walters EH, Abramson MJ, Matheson MC. Occupational exposure to pesticides are associated with fixed airflow obstruction in middle-age. Thorax 2017; 72:990-997. [PMID: 28687678 DOI: 10.1136/thoraxjnl-2016-209665] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Revised: 04/24/2017] [Accepted: 05/01/2017] [Indexed: 11/04/2022]
Abstract
RATIONALE Population-based studies have found evidence of a relationship between occupational exposures and Chronic Obstructive Pulmonary Disease (COPD), but these studies are limited by the use of prebronchodilator spirometry. Establishing this link using postbronchodilator is critical, because occupational exposures are a modifiable risk factor for COPD. OBJECTIVES To investigate the associations between occupational exposures and fixed airflow obstruction using postbronchodilator spirometry. METHODS One thousand three hundred and thirty-five participants were included from 2002 to 2008 follow-up of the Tasmanian Longitudinal Health Study (TAHS). Spirometry was performed and lifetime work history calendars were used to collect occupational history. ALOHA plus Job Exposure Matrix was used to assign occupational exposure, and defined as ever exposed and cumulative exposure unit (EU)-years. Fixed airflow obstruction was defined by postbronchodilator FEV1/FVC <0.7 and the lower limit of normal (LLN). Multinomial logistic regressions were used to investigate potential associations while controlling for possible confounders. RESULTS Ever exposure to biological dust (relative risk (RR)=1.58, 95% CI 1.01 to 2.48), pesticides (RR=1.74,95% CI 1.00 to 3.07) and herbicides (RR=2.09,95% CI 1.18 to 3.70) were associated with fixed airflow obstruction. Cumulative EU-years to all pesticides (RR=1.11,95% CI 1.00 to 1.25) and herbicides (RR=1.15,95% CI 1.00 to 1.32) were also associated with fixed airflow obstruction. In addition, all pesticides exposure was consistently associated with chronic bronchitis and symptoms that are consistent with airflow obstruction. Ever exposure to mineral dust, gases/fumes and vapours, gases, dust or fumes were only associated with fixed airflow obstruction in non-asthmatics only. CONCLUSIONS Pesticides and herbicides exposures were associated with fixed airflow obstruction and chronic bronchitis. Biological dust exposure was also associated with fixed airflow obstruction in non-asthmatics. Minimising occupational exposure to these agents may help to reduce the burden of COPD.
Collapse
Affiliation(s)
- Sheikh M Alif
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Shyamali C Dharmage
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.,Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Geza Benke
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Martine Dennekamp
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.,Graduate Entry Medical School, University of Limerick, Limerick, Ireland
| | - John A Burgess
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Jennifer L Perret
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.,Department of Respiratory and Sleep Medicine, Austin Hospital, Melbourne, Victoria, Australia
| | - Caroline J Lodge
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Stephen Morrison
- Department of Medicine, University of Queensland, Brisbane, Queensland, Australia
| | - David Peter Johns
- School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
| | - Graham G Giles
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.,Murdoch Childrens Research Institute, Melbourne, Victoria, Australia.,Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia
| | - Lyle C Gurrin
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.,Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| | - Paul S Thomas
- Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia
| | - John Llewelyn Hopper
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | | | - Bruce R Thompson
- Allergy Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia
| | - Iain H Feather
- Gold Coast University Hospital, Southport, Queensland, Australia.,Bond University, Robina, Queensland, Australia
| | - Roel Vermeulen
- Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Hans Kromhout
- Environmental Epidemiology Division, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - E Haydn Walters
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.,Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.,School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
| | - Michael J Abramson
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Melanie Claire Matheson
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.,Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
| |
Collapse
|
3
|
Baldi I, Carles C, Blanc-Lapierre A, Fabbro-Peray P, Druet-Cabanac M, Boutet-Robinet E, Soulat JM, Bouvier G, Lebailly P. A French crop-exposure matrix for use in epidemiological studies on pesticides: PESTIMAT. JOURNAL OF EXPOSURE SCIENCE & ENVIRONMENTAL EPIDEMIOLOGY 2017; 27:56-63. [PMID: 26696463 DOI: 10.1038/jes.2015.72] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2015] [Revised: 08/24/2015] [Accepted: 10/13/2015] [Indexed: 06/05/2023]
Abstract
Pesticide exposure assessment is a key methodological issue for epidemiological studies. The history of pesticide has proven difficult to obtain from individuals' report because of the wide range of active ingredients (AIs). We developed a crop-exposure matrix, which intends to reconstitute parameters of pesticide exposure in France since 1950. PESTIMAT is composed of tables crossing crops and AIs by year and providing the following metrics: (1) probability (proportion of farmers having used the AIs); (2) frequency (number of treatment days); and (3) intensity (application rate of the AIs in kg/ha). Metrics were obtained by the combination of six sources: (i) registration information from the Agriculture Ministry; (ii) information from agricultural bodies on products marketed; (iii) agricultural recommendations by the Plant Health Protection body; (iv) treatment calendars provided by farmers; (v) data from associations of farmers; and (vi) data from the industry. To date, 529 AIs usable between 1950 and 2010 are included in PESTIMAT: 160 fungicides; 160 herbicides; and 209 insecticides. When combined with duration and determinants of intensity, the metrics in PESTIMAT will make it possible to calculate exposure scores and to search for dose-effect relationships, an important criterion for causality judgment in epidemiology.
Collapse
Affiliation(s)
- Isabelle Baldi
- Equipe Santé Travail Environnement, Centre de Recherche INSERM U897, University Bordeaux Segalen, ISPED Case 11, Bordeaux, France
- INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
- CHU de Bordeaux, Service de Médecine du Travail, Bordeaux, France
| | - Camille Carles
- Equipe Santé Travail Environnement, Centre de Recherche INSERM U897, University Bordeaux Segalen, ISPED Case 11, Bordeaux, France
- INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
- CHU de Bordeaux, Service de Médecine du Travail, Bordeaux, France
| | - Audrey Blanc-Lapierre
- Equipe Santé Travail Environnement, Centre de Recherche INSERM U897, University Bordeaux Segalen, ISPED Case 11, Bordeaux, France
- INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
| | | | | | - Elisa Boutet-Robinet
- INRA, UMR1331, Toxalim, Research Centre in Food Toxicology, Toulouse, France
- Université de Toulouse, UPS, UMR1331, Toxalim, Toulouse, France
| | - Jean-Marc Soulat
- CHU de Toulouse Purpan, Service de Médecine du Travail, Toulouse, France
| | - Ghislaine Bouvier
- Equipe Santé Travail Environnement, Centre de Recherche INSERM U897, University Bordeaux Segalen, ISPED Case 11, Bordeaux, France
- INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France
| | - Pierre Lebailly
- INSERM, UMR1086-Cancers et Préventions, Caen, France
- University Caen Basse-Normandie, Caen, France
- Centre François Baclesse, Caen, France
| |
Collapse
|